The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, and the growing importance of technologies such as artificial intelligence (AI), the internet of things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Genomics in Healthcare: Molecular diagnosis biomarkers. Buy the report here.
According to GlobalData’s Technology Foresights, which uses over 443,000 patents to analyse innovation intensity for the healthcare industry, there are 200+ innovation areas that will shape the future of the industry.
Molecular diagnosis biomarkers is a key innovation area in genomics
Molecular biomarkers include biomolecules like nucleic acids and proteins that allow measurements in biological samples such as plasma, serum and cerebrospinal fluid. Diagnostic molecular biomarkers allow detection of a particular disease or disease subtype such as rapidly advancing cancer growth.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 120+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of molecular diagnosis biomarkers.
Key players in molecular diagnosis biomarkers – a disruptive innovation in the healthcare industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to molecular diagnosis biomarkers
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Waters||173||Unlock company profile|
|F. Hoffmann-La Roche||163||Unlock company profile|
|Vanda Pharmaceuticals||142||Unlock company profile|
|Nestle||69||Unlock company profile|
|Caris MPI||67||Unlock company profile|
|Critical Care Diagnostics||66||Unlock company profile|
|Biodesix||65||Unlock company profile|
|SomaLogic||63||Unlock company profile|
|Koninklijke Philips||57||Unlock company profile|
|Labrador Diagnostics||49||Unlock company profile|
|Novartis||48||Unlock company profile|
|Boston Medical Center||46||Unlock company profile|
|Cleveland Clinic Foundation||41||Unlock company profile|
|Compagnie Merieux Alliance||38||Unlock company profile|
|NantWorks||35||Unlock company profile|
|Ajinomoto||33||Unlock company profile|
|Abbott Laboratories||31||Unlock company profile|
|Shiseido||30||Unlock company profile|
|Myriad Genetics||29||Unlock company profile|
|Idexx Laboratories||28||Unlock company profile|
|PerkinElmer||27||Unlock company profile|
|LipoScience (formerly LipoMed)||25||Unlock company profile|
|Cancer Prevention and Cure||25||Unlock company profile|
|St. Jude Children’s Research Hospital||24||Unlock company profile|
|Exact Sciences||23||Unlock company profile|
|Johnson & Johnson||21||Unlock company profile|
|Matricelab Innove||21||Unlock company profile|
|True Health Diagnostics||20||Unlock company profile|
|Assistance Publique - Hopitaux de Paris||18||Unlock company profile|
|Globeimmune||18||Unlock company profile|
|Eutropics Pharmaceuticals||18||Unlock company profile|
|Sysmex||17||Unlock company profile|
|Clinical Genomics Pathology||17||Unlock company profile|
|Fetal Medicine Foundation||17||Unlock company profile|
|Ridge Diagnostics||17||Unlock company profile|
|Lifecycle Technologies||16||Unlock company profile|
|Genocea Biosciences||16||Unlock company profile|
|PT Soho Global Health||16||Unlock company profile|
|Royal Caribbean Cruises||16||Unlock company profile|
|Integrated Health Leaders||16||Unlock company profile|
|E. Merck KG||14||Unlock company profile|
|MeMed Diagnostics||14||Unlock company profile|
|Mayo Clinic||14||Unlock company profile|
|Thermo Fisher Scientific||14||Unlock company profile|
|Vertex Pharmaceuticals||13||Unlock company profile|
|Danaher||13||Unlock company profile|
|Prometheus Biosciences||13||Unlock company profile|
|Eurofins Scientific||13||Unlock company profile|
|Biotempus||13||Unlock company profile|
|AbbVie||12||Unlock company profile|
Source: GlobalData Patent Analytics
Waters is one of the leading patent filers in the field of molecular diagnosis biomarkers. Some other key patent filers in the field include F. Hoffman-La Roche and Vanda Pharmaceuticals.
In terms of application diversity, Boston Medical Center leads the pack, followed by Lifecycle Technologies and Johnson & Johnson. By means of geographic reach, Iddex Laboratories holds the top position, followed by Cancer Prevention and Cure and Fetal Medicine Foundation in second and third spots, respectively.
Biological markers have a wide range of applications including early diagnosis of a disease, efficient treatment selection and monitoring the output of therapeutic treatments. Genomics used with biological markers will allow analysis of genetic variations to identify the risk of diseases and track the outcome of therapeutic interventions in patients that would improve the overall quality of patient treatment.
To further understand the key themes and technologies disrupting the healthcare industry, access GlobalData’s latest thematic research report on Healthcare.